After-hours movers: lululemon, Broadcom, DocuSign and more
Joseph R. Holmes, VP & Chief Accounting Officer at Thermo Fisher Scientific Inc (NYSE:TMO), sold 385 shares of common stock on August 29th, 2025, for approximately $189661. The shares were sold at prices ranging from $492.615 to $492.633.
On the same day, Holmes exercised options to acquire 385 shares of Thermo Fisher Scientific common stock at a price of $253.99, for a total value of $97786.
Additionally, on August 28, Holmes disposed of 37 shares of common stock at a price of $489.74, totaling $18112. These shares were disposed of to cover tax obligations.
In other recent news, Thermo Fisher Scientific has been the focus of several analyst updates and company announcements. Bernstein SocGen Group raised its price target for Thermo Fisher to $570, citing strong performance and growth in pharmaceutical R&D consumables. Meanwhile, Stifel adjusted its price target to $583 while maintaining a Buy rating, following what it described as a strong second-quarter performance with notable market share gains. However, HSBC downgraded the stock to Hold, expressing concerns about the company’s medium-term growth prospects and the need for more evidence to support a growth rate exceeding 7% beyond 2027.
William Blair initiated coverage of Thermo Fisher with an Outperform rating, emphasizing the company’s synergies in the biopharmaceutical industry. Additionally, Thermo Fisher announced the retirement of its CFO, Stephen Williamson, effective March 2026, and named James R. Meyer as his successor. Meyer, who has been with the company since 2009, will assume the role in March 2026. These developments reflect a dynamic period for Thermo Fisher as it navigates analyst evaluations and leadership transitions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.